DOI: https://doi.org/10.22263/2312-4156.2019.1.72
Adamenko G.V.
Validation of the method for quantitative determination of chlorhexidine bigluconate in an antiseptic medicine
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2019;18(1):72-77.
Abstract.
The aim of this work was to adapt and validate the method for quantitative determination of chlorhexidine bigluconate in the antiseptic medicine «Vitasept-SKO».
The method for quantitative determination of chlorhexidine bigluconate by the absorption spectrophotometry in an antiseptic medicine containing ethanol 72,0±2,0 v/v % with 5,0±0,5 g/dm3 of chlorhexidine bigluconate was adapted and validated in terms of specificity, linearity, convergence, interlaboratory precision, accuracy and range of detectable contents.
The method enabled the determination of chlorhexidine bigluconate in the presence of other components constituting the medicine. The value of the analytical signal obtained while studying placebo did not exceed by more than 2,0% in magnitude the value of the analytical signal corresponding to the lower limit of the measured content of chlorhexidine bigluconate in the drug. Therefore, the method is specific.
The approximation coefficient must be at least 0,99 (0,9999). The intersection with the Y axis was no more than 2,0% of the value of the analytical signal corresponding to the 100% chlorhexidine bigluconate content (-0,24). The openability, calculated as the ratio between the average concentration determined according to the calibration curve and the nominal concentration, multiplied by 100% was within the limits of 98-102%. Hence, the method is linear.
The relative standard deviation (RSD) for the quantitative determination of model solutions did not exceed 2,0%, consequently the method is precise.
The degree of correspondence between the true value of the determined quantity and the results obtained by the validated method was established. The regularity is controlled by means of preparing model solutions of chlorhexidine bigluconate in the expected range of the determined content of the method. The range of the determined content according to the developed method makes up 4,5-5,5 mg/cm3 of chlorhexidine bigluconate.
Key words: validation, Vitasept-SKO, chlorhexidine bigluconate.
References
1. Godoval'nikov GV. Organization and Economics of pharmacy: prakt posobie. V 4 ch. Ch 1. Minsk, RB: Prof izd; 2015. 263 р. (In Russ.)
2. ISO/IEC 17025:2017(E). General competence requirements for testing and calibration laboratories [Elektronnyi resurs]. Moscow, RF: Analitika; 2018. 40 r. Rezhim dosutpa: http://aac-analitica.ru/. Data dostupa: 18.02.2019. (In Russ.)
3. Good manufacturing practice: TKP 030-2017 (33050). Vved 2017-09-01. Izd ofits. Minsk, RB: M-vo zdravookhraneniia Resp Belarus'; 2017. 218 р. (In Russ.)
4. Ivanov AI. Principles of ensuring the quality of production of medicines at the present stage of development of the world pharmaceutical market. Farmatsiia. 2009;(2):21-3. (In Russ.)
5. Ivanov AI, Sudarev IV. Management of pharmaceutical enterprise processes in terms of GMP requirements as a business system. Farmatsiia. 2008;(6):37-9. (In Russ.)
6. Reutskaya LA. To a question of development of national medicinal policy. Vestn Farmatsii. 2009;(3):5-15. (In Russ.)
7. M-vo zdravookhraneniia Resp Belarus', Tsentr ekspertiz i ispytanii v zdravookhranenii; Sheriakov A, red. State Pharmacopoeia of the Republic of Belarus (GF RB II): razrab na osnove Evrop Farmakopei. V 2 t. T 1. General methods of quality control of medicines: vved. v deistvie s 1 ianv 2013 g prikazom M-va zdravookhraneniia Resp Belarus' ot 25.04.2012 № 453. Molodechno, RB: Pobeda; 2012. 1217 р. (In Russ.)
8. Production of medicines. Validation of test procedures: TKP 432-2012 (02041). Vved 01.03.2013. Izd ofits. Minsk, RB: Departament farmatsevt prom-sti M-va zdravookhraneniia Resp Belarus'; 2012. 18 р. (In Russ.)
9. Production of medicines. Application of statistical methods of validation: TKP 438-2012 (02041). Vved 01.03.2013. Izd ofits. Minsk, RB: Departament farmatsevt prom-sti M-va zdravookhraneniia Resp Belarus'; 2012. 27 р. (In Russ.)
Information about authors:
Adamenko G.V. – senior lecturer of the Chair of Organization & Economy of Pharmacy with the course of the Faculty for Advanced Training & Retraining, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Organization & Economy of Pharmacy with the course of the Faculty for Advanced Training & Retraining. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Gennadiy V. Adamenko.
